Related Experiment Video
Updated: Oct 13, 2025

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
Predictive Clinical Decision Support System Using Machine Learning and Imaging Biomarkers in Patients With
Jose De Andres1, Amadeo Ten-Esteve2, Anushik Harutyunyan3
1Anesthesia Unit-Surgical specialties Department, Valencia University Medical School, Valencia, Spain; Multidisciplinary Pain Management Department, Department of Anesthesiology, Critical Care and Pain Management, General University Hospital, Valencia, Spain.
This study introduces a decision support system using brain imaging and clinical data to predict spinal cord stimulation (SCS) therapy success in chronic pain patients. The system significantly improves patient selection accuracy for SCS.
Area of Science:
- Neuroscience
- Medical Imaging
- Pain Management
Background:
- Chronic pain is linked to brain structure and function changes.
- Selecting patients for spinal cord stimulation (SCS) is challenging, with high explant rates.
- Current selection relies on functional variables and pain scores, lacking predictive accuracy.
Purpose of the Study:
- To evaluate imaging biomarkers, specifically functional connectivity (FC) and brain volumetry, in Failed Back Surgery Syndrome (FBSS) patients.
- To develop a clinical decision support system (CDSS) integrating neuroimaging and clinical data for predicting SCS therapy effectiveness post-trial.
Main Methods:
- Prospective, observational, single-center study using resting-state functional MRI (rs-fMRI).
- Region of interest (ROI) to ROI and seed-to-voxel analyses compared FC and volume changes.
- Machine learning models assessed clinical variables and imaging biomarkers to predict therapy responders (R-G).
Main Results:
- Volumetric differences identified in the left putamen; significant FC differences found in four brain area pairs, including the right insular cortex.
- Linear Discriminant Analysis (LDA) achieved the highest performance in the CDSS.
- The CDSS improved diagnostic accuracy for predicting SCS responders from 29% to 96%.
Conclusions:
- The left putamen and specific brain regions play a crucial role in FBSS.
- A CDSS incorporating imaging biomarkers can significantly enhance patient selection for SCS.
- This approach promises to improve long-term outcomes for patients undergoing SCS therapy.
More Related Videos
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023